13 matching records for EPIDERMAL GROWTH FACTOR.
ACTIVATED CHARCOAL - ANTIMONY TRISULFIDE - BISMUTH SUBNITRATE - DIOSCOREA VILLOSA ROOT - DOPAMINE - HUMAN EPIDERMAL GROWTH FACTOR - IPECAC - OREGANO - PICEA MARIANA RESIN - ROBINIA PSEUDOACACIA BARK - SEMECARPUS ANACARDIUM JUICE - SILVER NITRATE - SUS SCROF...
EPIDERMAL GROWTH FACTOR
ACTIVATED CHARCOAL - ANTIMONY TRISULFIDE - BISMUTH SUBNITRATE - DIOSCOREA VILLOSA ROOT - DOPAMINE - HUMAN EPIDERMAL GROWTH FACTOR - IPECAC - OREGANO - PICEA MARIANA RESIN - ROBINIA PSEUDOACACIA BARK - SEMECARPUS ANACARDIUM JUICE - SILVER NITRATE - SUS SCROF...
EPIDERMAL GROWTH FACTOR
SH-OLIGOPEPTIDE-1, SODIUM HYALURONATE
One or multiple immunoglobulins capable of binding to specific antigenic determinants and intended to be used for the qualitative and/or quantitative detection of human epidermal growth factor receptor 2 (HER2) protein, also known as HER2 or neu oncoprotein...
One or multiple immunoglobulins capable of binding to specific antigenic determinants and intended to be used for the qualitative and/or quantitative detection of epidermal growth factor receptor (EGFR) in a clinical specimen.
A collection of reagents and other associated materials intended to be used for the qualitative and/or quantitative detection of epidermal growth factor receptor (EGFR) in a clinical specimen, using an enzyme immunohistochemistry method.
A material which is used to verify the performance of an assay intended to be used for the qualitative and/or quantitative detection of epidermal growth factor receptor (EGFR) in a clinical specimen.
A collection of reagents and other associated materials intended to be used to evaluate a clinical specimen to predict or monitor the response to treatment with epidermal growth factor receptor (EGFR) inhibitors by determining the EGFR mutation status or mR...
A material which is used to verify the performance of an assay intended to be used for the qualitative and/or quantitative detection of human epidermal growth factor receptor 2 (HER2) protein, also known as HER2 or neu oncoprotein, in a clinical specimen.
One or multiple immunoglobulins capable of binding to specific antigenic determinants and intended to be used for the qualitative and/or quantitative detection of a ligand of epidermal growth factor receptor (EGFR) (e.g., amphiregulin, epiregulin) in a clin...
A collection of reagents and other associated materials intended to be used for the qualitative detection of the KRAS (v-ki-ras2 kirsten rat sarcoma viral oncogene homolog) mutation status and/or to evaluate a clinical specimen to predict or monitor the res...